AM
IDXX icon

AGF Management’s Idexx Laboratories IDXX Stock Holding History

AGF Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-952
Closed -$400K – 680
2025
Q1 		$400K Sell
952
-297
-24% -$129K ﹤0.01% 621
2024
Q4 		$516K Buy
+1,249
New +$548K ﹤0.01% 630
2024
Q3 		– Sell
-1,073
Closed -$523K – 696
2024
Q2 		$523K Sell
1,073
-2,528
-70% -$1.27M ﹤0.01% 628
2024
Q1 		$1.94M Buy
3,601
+2,759
+328% +$1.51M 0.01% 495
2023
Q4 		$467K Sell
842
-1,053
-56% -$494K ﹤0.01% 638
2023
Q3 		$829K Sell
1,895
-117
-6% -$58.3K 0.01% 582
2023
Q2 		$1.01M Buy
+2,012
New +$964K 0.01% 533
2023
Q1 		– Sell
-680
Closed -$277K – 776
2022
Q4 		$277K Buy
+680
New +$264K ﹤0.01% 728

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

AGF Management's IDXX Position: Q2 2025 in Review

AGF Management sold out of Idexx Laboratories (IDXX) in Q2 2025, closing a stake of 952 shares — an estimated $400K sold.

AGF Management first reported a position in IDXX in Q4 2022 and held it in 8 quarters. The position peaked at $1.94M in Q1 2024. 1,234 funds tracked by Wall St. Rank hold IDXX as of Q2 2025.

  • AGF Management reported no remaining Idexx Laboratories position as of Q2 2025 after selling out during the quarter.
  • AGF Management sold 952 Idexx Laboratories shares in Q2 2025, an estimated $400K.
  • AGF Management first reported a position in Idexx Laboratories in Q4 2022 and held it in 8 quarters.
  • AGF Management's Idexx Laboratories position peaked at $1.94M in Q1 2024.
  • 1,234 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2025.

Based on AGF Management's 13F filing for Q2 2025, filed 6 Aug 2025.